MIRA Pharmaceuticals, Inc.
MIRA
$1.20
-$0.04-3.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.43% | 55.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -25.95% | 17.11% | |||
| Operating Income | 25.95% | -17.11% | |||
| Income Before Tax | 25.67% | -17.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 25.67% | -17.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.67% | -17.41% | |||
| EBIT | 25.95% | -17.11% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 26.02% | -6.86% | |||
| Normalized Basic EPS | 26.05% | -6.84% | |||
| EPS Diluted | 26.02% | -6.86% | |||
| Normalized Diluted EPS | 26.05% | -6.84% | |||
| Average Basic Shares Outstanding | 0.51% | 9.88% | |||
| Average Diluted Shares Outstanding | 0.51% | 9.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||